Search - tctmd.com

Displaying 41 - 60 of 137

Sort: Relevancy | Date

Presentation TCT 2022

Wearable Device for Continuous, Noninvasive Fluid Status Monitoring in Hemodialysis Patients (Alio)

Presenter: David John Kuraguntla

September 17, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Industry News

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

January 22, 2022

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

Presentation TCT 2019

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Presenter: Carlo Briguori

September 29, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore

September 28, 2019

Presentation TCT 2019

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Presenter: Richard Solomon

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Presenter: Joost Daemen

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Presenter: Robert Schwartz

September 28, 2019

Presentation TCT 2019

Clinical Context of SOLO and Future Results and Implications for Who to Treat

Presenter: Naomi Fisher

September 27, 2019

Presentation TCT 2019

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Presenter: Chandan Devireddy

September 27, 2019

Advertisement

Wearable Device for Continuous, Noninvasive Fluid Status Monitoring in Hemodialysis Patients (Alio)

September 2022 News Roundup

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

December 2021 News Roundup

TCT 677: Renal denervation in a young patient with malignant hypertension

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

CIN Risk Prediction and Outcomes

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Clinical Context of SOLO and Future Results and Implications for Who to Treat

RADIANCE-HTN SOLO: In-Depth Analysis at 6 Months After Medication Titration and Review of RADIANCE-HTN Global Clinical Trial Program

RDN Procedure With the ReCor Paradise Technology: Anatomy, Treatment Location, Procedure Standardization and Simplicity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content